POLITICO – Everything you wanted to know about the EU’s pharma reform (but were too afraid to ask)

17 January 2023

Can the European Union bring eye-wateringly expensive medicines to the […]

CORREO FARMACEUTICO – Elisabeth Stampa Stampa, Presidenta de Medicines for Europe y Consejera Delegata de Medichem

31 March 2022

REGULATORY FOCUS – New reports address generics pricing, innovation in the EU

2 December 2021

Open

Open letter: Urgent call to amend the Temporary State Aid Framework to achieve the Recovery and Resiliency Facility objectives

17 November 2021

Margaritis Schinas and Adrian Van Den Hoven visited ELPEN

15 November 2021

IGBA Calls on all Stakeholders to Join the Biosimilars Movement on Advancing Access

1 November 2021

Digitalisation the key to efficient EU pharmaceutical regulation and easing of localised drug shortages

27 October 2021

“Digitalisation the key to efficient EU pharmaceutical regulation and easing […]

“Central Role For Industry Beckons As Europe Rebuilds After COVID” – Interview to Rebecca Guntern

25 October 2021

Generics And Biosimilars Must Become A Central Policy Pillar, Says […]

EU Industry Welcomes New Schengen Strategy’s Green Lanes

4 June 2021

“EU Industry Welcomes New Schengen Strategy’s Green Lanes” Read more

Opinion piece by Christoph Stoller for Friends of Europe

3 June 2021

“Too much at stake in the EU pharma strategy to […]